BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17868461)

  • 21. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
    Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease.
    Eickhoff P; Valipour A; Kiss D; Schreder M; Cekici L; Geyer K; Kohansal R; Burghuber OC
    Am J Respir Crit Care Med; 2008 Dec; 178(12):1211-8. PubMed ID: 18836149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.
    Oh YM; Jeong BH; Woo SY; Kim SY; Kim H; Lee JH; Lim SY; Rhee CK; Yoo KH; Lee JH; Yoon HK; Sin DD; Lee SD; Kim EK; Park HY;
    Ann Am Thorac Soc; 2015 Jul; 12(7):1005-12. PubMed ID: 26010877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease.
    Bon JM; Leader JK; Weissfeld JL; Coxson HO; Zheng B; Branch RA; Kondragunta V; Lee JS; Zhang Y; Choi AM; Lokshin AE; Kaminski N; Gur D; Sciurba FC
    PLoS One; 2009 Aug; 4(8):e6865. PubMed ID: 19718453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased systemic inflammation is a risk factor for COPD exacerbations.
    Groenewegen KH; Postma DS; Hop WC; Wielders PL; Schlösser NJ; Wouters EF;
    Chest; 2008 Feb; 133(2):350-7. PubMed ID: 18198263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
    Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
    Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
    Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD.
    Kim WD; Kim WS; Koh Y; Lee SD; Lim CM; Kim DS; Cho YJ
    Chest; 2002 Aug; 122(2):437-44. PubMed ID: 12171814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexisting COPD in elderly asthma with fixed airflow limitation: Assessment by DLco %predicted and HRCT.
    Tamada T; Sugiura H; Takahashi T; Matsunaga K; Kimura K; Katsumata U; Ohta K; Ichinose M
    J Asthma; 2017 Aug; 54(6):606-615. PubMed ID: 27780366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-resolution computed tomography quantitation of emphysema is correlated with selected lung function values in stable COPD.
    D'Anna SE; Asnaghi R; Caramori G; Appendini L; Rizzo M; Cavallaro C; Marino G; Cappello F; Balbi B; Di Stefano A
    Respiration; 2012; 83(5):383-90. PubMed ID: 21832824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.
    Kirby M; Owrangi A; Svenningsen S; Wheatley A; Coxson HO; Paterson NA; McCormack DG; Parraga G
    Thorax; 2013 Aug; 68(8):752-9. PubMed ID: 23604381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity.
    Cockayne DA; Cheng DT; Waschki B; Sridhar S; Ravindran P; Hilton H; Kourteva G; Bitter H; Pillai SG; Visvanathan S; Müller KC; Holz O; Magnussen H; Watz H; Fine JS
    PLoS One; 2012; 7(6):e38629. PubMed ID: 22701684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interleukin-17 expression and clinical significance in the lung tissue of patients with stable chronic obstructive pulmonary disease].
    Chen X; Cao J; Chen BY
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(26):2086-90. PubMed ID: 27468622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COPD: Do Imaging Measurements of Emphysema and Airway Disease Explain Symptoms and Exercise Capacity?
    Kirby M; Pike D; Sin DD; Coxson HO; McCormack DG; Parraga G
    Radiology; 2015 Dec; 277(3):872-80. PubMed ID: 26151081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood MCP-1 levels are increased in chronic obstructive pulmonary disease patients with prevalent emphysema.
    Di Stefano A; Coccini T; Roda E; Signorini C; Balbi B; Brunetti G; Ceriana P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1691-1700. PubMed ID: 29872287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between markers of emphysema and more severe chronic obstructive pulmonary disease.
    Boschetto P; Quintavalle S; Zeni E; Leprotti S; Potena A; Ballerin L; Papi A; Palladini G; Luisetti M; Annovazzi L; Iadarola P; De Rosa E; Fabbri LM; Mapp CE
    Thorax; 2006 Dec; 61(12):1037-42. PubMed ID: 16769715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative emphysema assessment of pulmonary function impairment by computed tomography in chronic obstructive pulmonary disease.
    Wang G; Wang L; Ma Z; Zhang C; Deng K
    J Comput Assist Tomogr; 2015; 39(2):171-5. PubMed ID: 25474145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study.
    Crapo JD; Gupta A; Lynch DA; Turner AM; Mroz RM; Janssens W; Ludwig-Sengpiel A; Koegler H; Eleftheraki A; Risse F; Diefenbach C
    Respir Res; 2023 Nov; 24(1):290. PubMed ID: 37978492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.